KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Exact Sciences (EXAS) Debt to Equity (2016 - 2024)

Exact Sciences (EXAS) has disclosed Debt to Equity for 15 consecutive years, with $0.02 as the latest value for Q1 2024.

  • Quarterly Debt to Equity fell 2.39% to $0.02 in Q1 2024 from the year-ago period, while the trailing twelve-month figure was $0.02 through Mar 2024, down 2.39% year-over-year, with the annual reading at $0.02 for FY2023, 3.25% down from the prior year.
  • Debt to Equity for Q1 2024 was $0.02 at Exact Sciences, roughly flat from $0.02 in the prior quarter.
  • The five-year high for Debt to Equity was $0.02 in Q4 2022, with the low at $0.01 in Q1 2021.
  • Average Debt to Equity over 5 years is $0.01, with a median of $0.02 recorded in 2023.
  • The sharpest move saw Debt to Equity tumbled 97.23% in 2020, then skyrocketed 159.41% in 2022.
  • Over 5 years, Debt to Equity stood at $0.01 in 2020, then tumbled by 37.96% to $0.01 in 2021, then surged by 164.99% to $0.02 in 2022, then fell by 3.25% to $0.02 in 2023, then grew by 0.4% to $0.02 in 2024.
  • According to Business Quant data, Debt to Equity over the past three periods came in at $0.02, $0.02, and $0.02 for Q1 2024, Q4 2023, and Q3 2023 respectively.